Jun 29 |
ADC Therapeutics SA (NYSE:ADCT) Shares Could Be 50% Below Their Intrinsic Value Estimate
|
Jun 27 |
ADC Therapeutics to join Russell 2000 index
|
Jun 27 |
ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
|
Jun 13 |
Stocks to Buy: 3 Biotech Bargains Delivering Breakthroughs on a Budget
|
Jun 6 |
Limiting Concerns On ADC Therapeutics' Prospects
|
May 30 |
ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference
|
May 14 |
ADC Therapeutics down 7% following new corporate presentation
|
May 10 |
ADC Therapeutics First Quarter 2024 Earnings: In Line With Expectations
|
May 9 |
Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
|
May 9 |
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
|